You're not too young for bowel cancer
Colorectal or bowel cancer is one of the most commonly diagnosed cancers, affecting approximately 1 in 20 Australians.
Jul 15, 2026
0
4
Oncology news
Immune ecotypes may explain multiple myeloma outcomes missed by disease staging
Researchers at The University of Texas MD Anderson Cancer Center have created a comprehensive single-cell map of the tumor immune microenvironment in multiple myeloma and its precursor conditions. The study provided insights ...
Jul 15, 2026
0
2
Virtual, sustained smoking cessation program for cancer patients doubles quitting rate, clinical trial shows
A new study shows that a smoking cessation treatment program delivered in community oncology care settings can nearly double quit rates for patients with cancer who currently smoke. Investigators from Mass General Brigham ...
Jul 14, 2026
0
3
Researchers uncover new therapeutic vulnerability in one of the most aggressive childhood leukemia
An international team led by the Josep Carreras Leukaemia Research Institute (IJC) in Barcelona, the Centre for Genomics and Oncological Research (GENyO) and the University of Granada (UGR) has identified a new biological ...
Jul 14, 2026
0
4
Scientists uncover genetic clues from a tumor-prone reptile that could advance cancer research
A new study led by experts at the University of Nottingham suggests a pet gecko with an unusually high risk of tumors may be a promising model for understanding how cancer develops and spreads. The findings of the study, ...
Jul 14, 2026
0
12
For your health—can your breakfast help lower cancer risk?
Don't sleep on the cancer prevention benefits of a healthy breakfast. Whether it's oatmeal, whole-wheat toast, berries in Greek yogurt or other healthy combinations—starting the morning with simple, whole foods is a great ...
Jul 14, 2026
0
6
Immunotherapy shows long-term promise in aggressive lymphoma
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical ...
Jul 14, 2026
0
6
Two-isotope imaging could guide targeted alpha therapy for metastatic prostate cancer
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the advanced stages of the disease still requires more precise tools. Researchers at the Helmholtz-Zentrum ...
Jul 14, 2026
0
4
Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory Phase I clinical study, the vaccine was well tolerated and generated immunologic and clinical ...
Jul 14, 2026
0
4
KRAS-targeting drugs show promise for rare appendix cancer
Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.
Jul 14, 2026
0
2
